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CARDIAC AND PULMONARY 
REPLACEMENT 
IMPROVED HYPOTHERMIC 
PRESERVATION OF RAT 
HEARTS BY FUROSEMIDE 
The effect of furosemide, a blocker of the Na+/K+/CI - cotransporter, on 
hypothermic preservation frat hearts was studied with use of the Langendorff 
perfusion system and electron microscopy. Furosemide significantly improved 
the mechanical recovery and the coronary flow of the hearts preserved for 8 
hours in St. Thomas' Hospital cardioplegic solution at a temperature of4 ° C. 
Furosemide at the concentration f 100 pmol/L was found to have an optimal 
effect, whereas at high concentrations (1000/xmol/L) it was found to have toxic 
effects. In addition, furosemide r duces the time elapsed between the end of the 
preservation time and the resumption of myocardial contractions. Ultrastruc- 
tural evaluations were done in which the presence of swollen mitochondria was 
chosen as a criterion of hypothermic schemic damage to the myocardium. 
Morphometric analysis indicated that the mitochondrial volume of hearts 
stored for 8 hours in St. Thomas' Hospital cardioplegic solution increased by 
72% as compared with the mitochondriai volume of hearts that were not 
exposed to the hypothermic is hemic onditions (control group). The addition 
of 100/xmol/L furosemide to the cardioplegic solution resulted in a significant 
reduction of mitochondrial swelling during the period of 8 hours' storage, 
which amounted only to 28% as compared with the figure for the control group. 
The reduction of mitochondrial swelling by furosemide and the improved 
mechanical and coronary flow recoveries are thought to be related to the 
blocking of the sarcolemmal Na+/K+/CI - cotransporter and consequently he 
reduction of the Na + influx during hypothermic ischemic storage. (J THORAC 
CARDIOVASC SURG 1995;110:523-31) 
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H eart transplantation is a successful treatment for irreversible, final stage cardiac failure. However, 
despite intensive efforts that have been conducted 
toward extending heart preservation, to date, the 
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time allowed for cold ischemic preservation of the 
heart is limited to 4 to 5 hours because reliable 
recovery of the heart cannot otherwise be achieved. 1 
The most widely used procedure for heart preserva- 
tion is based on a single infusion of a cold crystalloid 
cardioplegic solution, followed by hypothermic stor- 
age. The crystalloid cardioplegic solutions are made 
up of either extracellular-like formulation, such as 
St. Thomas' Hospital cardioplegic solution (ST), or 
as intracellular-like formulation, such as University 
of Wisconsin cold storage solution. 
During hypothermic ischemic storage the intra- 
cellular ionic homeostasis i disturbed. The most 
drastic change is a large influx of Na+, 2 followed by 
influx of water and an increase in cell volume) 
Mitochondrial damage is one of the main factors 
that accounts for the depression of cardiac function. 
Scanning electron microscopy of the ischemic heart 
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shows derangement of individual cells because of 
the presence of interstitial edema, dissociation of 
myofibrils, loss of myofilaments, and swollen mito- 
chondria with various degrees of cristae disorienta- 
tion. 4-7 
In a previous study we demonstrated, with 23Na 
nuclear magnetic resonance techniques, that loop 
diuretic agents, such as furosemide and bumetanide, 
can reduce the Na + influx during hypothermic heart 
storage when added to Krebs-Henseleit solution. 8It 
was suggested that by blocking the Na+/K+/C1 - 
cotransporter located in the sarcolemma the accu- 
mulation of intracellular Na + is decreased, leading 
to protection of the myocardial cells during hypo- 
thermic ischemia. 
In this study, we investigated the hemodynamic 
effects of furosemide on heart recovery after 8 hours 
of preservation i ST cardioplegic solution at 4 ° C. 
In addition, we conducted an electron microscopy 
study that measured the changes in myocardial 
mitochondrial volumes after 8 hours of hypothermic 
preservation i ST cardioplegic solution. 
Material and methods 
Hemodynamic study. All animals received humane 
care in compliance with the "Principles of Laboratory 
Animal Care" formulated by the National Society for 
Medical Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). Male Sprague-Dawley rats weighing 300 to 400 gm 
were randomly divided into two experimental groups. 
They were anesthetized with phenobarbital sodium (20 
mg per rat intraperitoneally), and the hearts were excised 
and placed immediately in iced heparinized saline solu- 
tion. After cessation of contractions, the aortas were 
cannulated for Langendorff perfusion. Ventricular pres- 
sure was measured by a thin latex balloon, which was 
inserted into the left ventricle across the mitral valve. The 
balloon was inflated with aqueous olution to achieve an 
initial end-diastolic pressure of 10 to 15 mm Hg and was 
then kept isovolumic throughout the experiment. This 
balloon was connected by a polyethylene tube to a pres- 
sure transducer that transmitted the pressure signals to an 
IBM AT-286 computer (IBM Corp., Armonk, N.Y.) that 
analyzed and computed the intraventricular pressure and 
its derivative (dP/dt). Immediately on connection to the 
perfusion system the hearts were paced (Harvard stimu- 
lator, Harvard Apparatus, S. Natick, Mass.) at a rate of 
300 beats/min. Coronary flow was measured by collecting 
the effluent liquid that came out of the heart into a 
measuring vessel. 
The experimental hearts were divided into six groups 
that consisted of five groups that were treated with 
furosemide, each with a different concentration (10, 50, 
100, 300, and 1000 txmol/L), and of one control group that 
was not treated with furosemide. In the groups treated 
with furosemide the experimental protocol was as follows. 
Fifteen minutes of perfusion with a phosphate-free Krebs- 
Henseleit (KH) buffer solution at a temperature of 37 ° C 
and in a pressure of 95 cm of water was followed by 15 
minutes of perfusion with KH solution with furosemide 
(Sigma Chemical Co., St. Louis, Mo.). Left ventricular 
pressure, dP/dt, and coronary flow were measured every 5 
minutes. After perfusion for 30 minutes at 37 ° C, the 
hearts were perfused for 2 minutes with ST solution plus 
furosemide at a temperature of 4 ° C. In this 2-minute 
period the heart contractions were stopped. Then the 
hearts were placed in a 250 ml flask containing the same 
ST plus furosemide cardioplegic solution. This solution 
was kept cooled at a temperature of 4 ° C throughout 8 
hours of preservation. 
At the end of the preservation time, the hearts were 
reconnected to the Langendorff perfusion system and 
perfusion with KH buffer solution at a temperature of
37 ° C was commenced. The hearts were paced initially at 
a rate of 180 beats/min for 10 minutes, then at a rate of 
300 beats/min for 20 minutes. The overall reperfusion 
time was 30 minutes, during which measurements of left 
ventricular pressure, dP/dt, and coronary flow were taken 
in cycles of every 5 minutes. The control group underwent 
the same protocol, but without furosemide. 
The KH solution contained the following components: 
121 mmol/L NaC1, 5.9 mmol/L KC1, 1.75 mmol/L CaCI2, 
1.2 mmol/L MgSO4, 23 mmol/L NaHCO3, and 11 mmol/L 
glucose. The solution was bubbled continuously with a 
mixture of 95% oxygen and 5% carbon dioxide, and the 
pH was 7.4. The ST cardioplegic solution contained the 
following components: 110 mmol/L NaC1, 16 mmol/L KC1, 
16 mmol/L MgC12, 1.2 mmol/L CaC12, and 10 mmol/L 
NaHCO3, and the pH was 7.8. 9 
Electron microscopy study. Male Sprague-Dawley rats 
weighing 300 to 400 gm were randomized into three 
experimental groups. Rats in group 1 (8 hours, control; 
8h/c) were anesthetized with phenobarbital sodium (20 
mg per rat intraperitoneally). Hearts were excised and 
placed immediately in iced heparinized saline solution. 
After contractions ceased, the aortas were cannulated for 
Langendorff perfusion. These hearts were perfused ini- 
tially with KH solution at a pressure of 95 cm of water for 
20 minutes, followed by 2 minutes of perfusion with the 
cold (4 ° C) ST solution. 9Then the hearts were placed in a 
beaker containing cold ST solution and stored for 8 hours. 
At the end of the storage period the hearts were perfused 
with phosphate-buffered saline solution containing 2% 
glutaraldehyde for 3 minutes. A cubic (0.5 cm 3) section of 
myocardial tissue was removed via a cut beneath the left 
auricle. This myocardial tissue was then cut into smaller 
cubes (1 mm 3) and placed in the glutaraldehyde solution 
for fixation. 
Rats in group 2 (8 hours, furosemide treatment; 8h/f) 
underwent the same procedure but with the following 
variations. The preischemic 20 minutes of perfusion was 
divided into 5 minutes of perfusion with KH solution only, 
followed by 15 minutes of perfusion with KH solution 
containing 100 txmol/L furosemide. The ST solution in 
this group contained 100 txmol/L furosemide as well. 
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Fig. 1. A, Left ventricular pressure (LVP) at preischemic phase. B, dP/dt of left ventricle at preischemic 
phase. Open circles represent control group, filled circles represent group treated with 50 txmol/L 
furosemide, and triangles represent group treated with 100 ~mol/L furosemide. Results are expressed as 
mean plus or minus standard eviation, n = 5. 
Rat hearts in group 3 (not exposed to hypothermic 
ischemia; 0h/c) were cannulated on the Langendorff per- 
fusion system as described and perfused with KH solution 
only for 20 minutes. After this period, the hearts were 
perfused immediately with glutaraldehyde followed by 
removal of the myocardial tissue as described for the 
other groups. 
For electron microscopy, the 1 mm 3 blocks of glutaral- 
dehyde-fixed myocardium were washed with phosphate- 
buffered saline solution, dehydrated in ethanol, post-fixed 
with 1% OsO4 in barbital (Veronal)-acetate buffer, pH 
7.4, for 1 hoar at 4 ° C, dehydrated in ethanol and pro- 
pylene oxide, and embedded in araldite. 
Morphometry. Analysis of mitochondrial size was done 
on electron micrographs of thin araldite sections at a 
magnification of ×25,000. The perimeter and area of the 
mitochondria were measured by a MOP-Vidioplan system 
(Kontron, Munich, Germany) with the standard program. 
For each heart sample, the measurements were done on 
100 different mitochondria, rbitrarily selected from five 
micrographs of different sections representing different 
areas of the tissue block. To rule out the possibility of 
irregularity of mitochondrial shape, which may affect he 
correlation of area to volume, we also calculated the form 
factor of each sample, as defined by the correlation 
47r x area 
Form factor - Perimeter2 
In all samples measured the form factors were similar 
(0.75 +- 0.08), indicating that direct correlation of area to 
volume can be made. 
Statistical analysis. Results are expressed as the mean 
plus or minus the standard eviation. Statistical signifi- 
cance was tested by one-way analysis of variance, with the 
multiple range test Scheffe procedure, and Student's t test 
for paired observations. A value ofp < 0.05 was consid- 
ered to indicate a significant difference} ° 
Results 
Hemodynamic study. The preischemic effect of 
furosemide on left ventricular pressure and dP/dt are 
summarized in Fig. 1. The results indicate no signifi- 
cant difference between the control group and the 
groups treated with 50/.~mol/L furosemide or with 100 
/~mol/L furosemide. However, the results obtained 
after 8 hours of preservation i the ST cardioplegic 
solution indicated that the group treated with 100 
/~mol/L furosemide achieved a significantly higher 
level of mechanical recovery during the 30 minutes 
of reperfusion as shown in Fig. 2. Despite the 
positive mechanical effect of furosemide that was 
found in the group treated with 50 /~mol/L furo- 
semide, the results in this group did not achieve 
statistical significance compared with those in the 
control group. 
Fig. 3 summarizes the percentage of mechanical 
recovery after 8 hours of preservation in the ST 
cardioplegic solution. These results were obtained 
by calculating the ratio between the values obtained 
after 15 minutes of perfusion in the preisehemic 
phase (before furosemide administration) and the 
values obtained at the end of the 30 minutes of 
reperfusion (after the nd of the preservation time). 
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Fig. 2. Recovery during 30 minutes of reperfusion, started after 8 hours of preservation i  ST cardioplegic 
solution. A, Left ventricular pressure (LVP) recovery. B, dP/dt recovery. Open circles represent control 
group, filled circles represent group treated with 50 /,mol/L furosemide, and triangles represent group 
treated with 100 ~mol/L furosemide. Results are expressed as mean plus or minus standard eviation, n = 5. 
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Fig. 3. Recovery percentage after 8 hours of preservation i ST cardioplegic solution. Percentage was 
calculated from ratio between preischemic values (after 15 minutes of perfusion) and values at end of 30 
minutes of reperfusion. A, Left ventricular pressure (LVP) recovery percentage. B, dP/dt recovery 
percentage. 1, Control group; 2, group treated with 50 /xmol/L furosemide; 3, group treated with 100 
txmol/L furosemide. 
It is clearly shown in Fig. 3 that the treatment with 
100 /xmol/L furosemide improved drastically the 
mechanical recovery. An important parameter was 
obtained by calculating the time that elapsed until 
the hearts howed mechanical work after the 8 hours 
of preservation. None of the hearts in the control 
group showed mechanical work within the first 5 to 
10 minutes of reperfusion. However, all the hearts in 
the treated groups (50 ~mol/L and 100 /xmol/L 
furosemide) showed mechanical work within the 
first 2 minutes of reperfusion. 
The effects of furosemide on left ventricular pres- 
sure and dP/dt were tested in three additional 
concentrations: 10 /xmol/L, 300 txmol/L, and 1000 
/xmol/L. Furosemide concentrations of 10 /xmol/L 
and 300/zmol/L were found to have no significant 
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Table I. Preischemic oronary flow* 
Furosemide (ml/min) 
Time Control 
(rain) (ml/min) 50 ixmoI/L 100 tarnol/L 
5 17.1 ± 3.4 17.0 ± 2.6 19.2 ± 2.3 
10 17.6 ± 3.4 16.7 ± 2.3 18.8 ± 1.8 
15 17.4 ± 3.8 16.2 ± 2.3 18.8 ± 1.8 
20 17.7 ± 4.9 16.5 ± 2.5 20.8 ± 1.8 
25 17.1 ± 5.3 17.0 ± 2.6 21.4 ± 1.9 
30 17.1 ± 5.3 17.5 - 2.5 21.4 ± 1.9 
*The coronary flow as a function of the time elapsed from mounting of the 
hearts on the Langendorff perfusion system, n = 5. 
effect on the mechanical recovery of the hearts. 
However, the hearts treated with these two concen- 
trations !also resumed mechanical work after the 8 
hours of preservation within the first 2 minutes of 
reperfusion. Furosemide at the concentration of 
1000 ~mol/L was found to have toxic effect. Hearts 
treated with this concentration showed no recovery 
at all. 
Tables I and II summarize the coronary flow 
results obtained uring perfusion at the preischemic 
phase and uring reperfusion at the postischemic 
phase. These results indicate no significant differ- 
ence between the control and the treated groups 
during perfusion in the preischemic phase. How- 
ever, it ig important to note that in the group treated 
with 100/xmol/L furosemide, a significant difference 
was found between the values obtained at the end of 
15 minutes, of perfusion and the values obtained 
after 30 minutes of perfusion (that is, 15 minutes 
after the onset of furosemide administration). The 
coronary flow results during reperfusion after the 8 
hours of preservation in ST solution indicate no 
significant difference between the control group and 
the group treated with 50/xmol/L furosemide. How- 
ever, th e coronary flow in the group treated with 100 
~mol/L furosemide was significantly higher than 
that in the control group after the 8 hours of 
preselvation. 
Electron microscopy study. Swollen mitochon- 
dria were chosen as a primary criteria of hypother- 
mic isch#mic damage in the myocardium. Table III 
summarizes the area of the mitochondrial section of 
hearts in each experimental group. We measured 
100 mit0chondria per heart. Eight hours of storage 
in the ST cardioplegic solution for the 8h/c hearts 
resultedi in a considerable increase in mitochondrial 
volume ias compared with that in the immediately 
fixed control 0h/c hearts (Fig. 4). The mitochondria 
I 
in the 81a/c hearts (Fig. 5) were highly dilated and 
exhibited considerably arger average section areas 
Table II. Postischemic oronary flow* 
Furosemide (ml/min) 
Time Control 
(rain) (ml/min) 50 p, mol/L 100 tzmol/L 
5 - -  7.7 ± 1.3 14.0 ± 3.2 
10 10.1 ± 1.9 7.7 ± 1.3 14.4 ± 3.8 
15 9.7 ± 2.1 8.7 ± 1.5 14.2 ± 3.4 
20 9.7 ± 1.9 8.7 -+ 1.5 14.2 -+ 3.7 
25 9.7 ± 1.9 9.2 -+ 1.0 13.8 ± 3.0 
30 9.1 ± 1.6 9.0 ± 0.8 13.4 ± 3.3 
*The coronary flow after 8 hours of preservation i  ST solution measured 
as a function of the time elapsed from the onset of reperfusion,  = 5. 
Table III. Mitochondrial average section areas* 
Area (Urn 2) 
Heart 8h/c 8h/f Oh/c 
1 0.62 ± 0.39 0.43 ± 0.29 0,31 ± 0.21 
2 0.50 ± 0.31 0.34 ± 0.24 0.28 -+ 0.17 
3 0.44 ± 0.27 0.34 -+ 0.16 0.36 -+ 0.25 
4 0.46 -+ 0.32 0.34 ± 0.19 0.22 -+ 0.14 
5 0.53 + 0.32 0.46 -- 0.27 0.31 ± 0.24 
*Mitochondrial average section areas of five hearts in each experimental 
group. The measurements were done on 100 mitochondria per heart. The 
results represent variation within the hearts in each group, as well as within 
mitochondria neach heart. Hearts in the 8h/c group underwent 8 hours of 
hypothermic preservation with ST only. Hearts in the 8h/f group under- 
went 8 hours of hypothermic preservation with ST plus 100 p~mol/L 
furosemide. In the 0h/c group, hearts were not exposed to hypothermic 
preservation. Significance was tested by one-way analysis of variance with 
multiple range test indicating p < 0.0001. 
as compared with those of the 0h/c hearts. Morpho- 
metric analysis indicated that the average section 
area of the mitochondria in the 8h/c hearts in- 
creased by 72% as compared with that in the 0h/c 
hearts. Hypothermic ischemic storage of hearts in 
the ST cardioplegic solution containing 100/xmol/L 
furosemide (Sh/f) resulted in considerably improved 
preservation of the myocardium as indicated by the 
morphologic findings of the mitochondria (Fig. 6). 
This concentration of furosemide was selected be- 
cause it gave a good inhibitory effect of the Na influx 
and an optimal mechanical recovery, s In most of 
these myocardia, the mitochondria were almost 
identical to those found in the 0h/c hearts in shape 
and section area sizes. Morphometric analysis re- 
vealed that the increase in the average section area 
of the mitochondria in the 8h/f hearts was only 28% 
as compared with that of the 0h/c hearts (Fig. 7). 
Discussion 
In this study we demonstrated that furosemide, 
preischemically introduced and added to the ST 
cardioplegic solution, protects the myocardium of 
the heart during an 8-hour period of preservation. 
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Fig. 4. Electron micrograph of araldite myocardial section of rat heart that was not exposed to 
hypothermic schemic onditions, fixed immediately after excision (original magnification ×45,000). 
Fig. 5. Electron micrograph of araldite myocardial section of rat heart fixed after 8 hours of hypothermic 
ischemic preservation with ST solution. Note increase in size and decrease in density of mitochondria as 
compared with those in Fig. 4 (original magnification ×45,000). 
This protection was indicated by the density, shape, 
and morphometry of the mitochondria nd by im- 
proved mechanical recovery and coronary flow. In 
an earlier study we demonstrated that loop diuretics 
such as furosemide and bumetanide reduced the 
large increase in intracellular Na + accumulation 
during hypothermic ischemic preservation with 
KH. s This reduction in the intracellular accumula- 
tion of Na + is believed to be a result of blocking of 
the loop diuretic-sensitive Na+/K+/C1 - cotrans- 
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Fig. 6. Electron micrograph of araldite myocardial section of rat heart fixed after 8 hours of preservation 
with ST containing 100/xmol/L furosemide. Note resemblance ofmitochondrial size and density to those 
of mitochondria n Fig. 4 (original magnification ×45,000). 
porter, located in the myocardial sarcolemma. 11 Our 
hypothesis was that under hypothermic ischemic 
conditions Na/K adenosinetriphosphatase is no 
longer active, which causes a large accumulation of 
Na ÷ inside the myocardial cells. Under the same 
conditions 1Lhe Na+/K+/C1 - cotransporter, which 
operates passively, without using adenosine triphos- 
phate hydrolysis for energy supply, plays a major 
role in the influx of Na+. 12-14 As a consequence of 
the intracellular Na + accumulation, large amounts 
of water penetrate the myocardial cell, causing the 
cell to swell. 3 Because mitochondrial membranes 
are readily permeable to water, the accumulated 
water in the cytosol may enter into the mitochon- 
drial matrb~, causing mitochondrial swelling fol- 
lowed by idisorientation of the cristae. Blocking the 
Na+/K+/CI- cotransporter by furosemide reduces 
the intracellular Na + accumulation, as indicated in 
our previous tudy, 8 and as a consequence r duces 
intracellular and intramitochondrial water accumu- 
lation. This was indicated in this study by measure- 
ment of :mitochondrial volumes. These effects are 
expected to improve the functional recovery of the 
heart after hypothermic preservation, as was indeed 
found experimentally in this study. 
Furosemide in the concentration of 100 /xmol/L 
was found to have the most potent effect on both the 
mechanical recovery and the coronary flow. Al- 
though the results of our previous 23Na nuclear 
magnetic resonance study indicated that furosemide 
at a concentration as low as 10 /xmol/L achieved 
maximal reduction in the intracellular Na ÷ accumu- 
lation in hearts stored in KH solution, this concen- 
tration was found to have no significant effect on the 
mechanical recovery of the hearts stored in ST 
cardioplegic solution. Thus the concentration range 
for the Na ÷ transport inhibition may be different 
between the two preservation solutions or the effect 
of furosemide on the mechanical recovery involves 
other factors besides the intracellular Na + accumu- 
lation, such as its effects on the coronary flow. It is 
important to note that measurement of the intracel- 
lular Na ÷ concentration i hearts preserved in ST 
cardioplegic solution is difficult because of the high 
concentration of K ÷ in this solution. A high concen- 
tration of K + reduces the Dy-triethylenetetramine- 
hexaacetic acid-induced chemical shift between the 
extracellular and intracellular compartments, abol- 
ishing the ability to discriminate between these two 
compartments. 
Furosemide at a high concentration (1000/xmol/L) 
was found to have toxic effects on the myocardium. 
This evidence agrees with findings of previous tud- 
ies that indicated that high doses of furosemide 
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markedly reduced rat heart recovery, even after 25 
minutes of ischemia. 15 Furosemide reduces the time 
elapsed between the end of ischemic and hypother- 
mic preservation and the resumption of myocardial 
contraction on reperfusion. This phenomenon can 
be explained by the time required by the myocardial 
cells to reestablish ionic homeostasis on both sides 
of the sarcolemma. In the treated groups, lower 
intracellular concentrations of Na ÷ brought shorter 
elapsed times until the resumption of myocardial 
contraction. Administration of 100 /xmol/L furo- 
semide in the preischemic phase caused a significant 
elevation in the coronary flow. This finding agrees 
with the previous observations that indicated 
that furosemide increases coronary flow in a dose- 
dependent manner. Is Because furosemide had no 
inotropic effect during the preischemic phase, it can 
be assumed that the levation in the coronary flow 
was caused by a vasodilative ffect of furosemide on 
the coronary endothelial cells. Recently, it was 
documented in the literature that dministration of
furosemide caused an increase of the synthesis of 
prostaglandin E 2 in the kidney. 16 Moreover, direct 
correlation was found between the elevation of 
prostaglandin E 2 concentration and the degree of 
vasodilative ffect on the kidney's blood vessels. 17 
This vasodilative ffect of furosemide was blocked 
when indomethacin, known as a prostaglandin syn- 
thesis blocker, was used.17 The prostaglandins I 2and 
E 2 are known to have very potent vasodilative effects 
on the cardiovascular system. In studies done in 
dogs it was shown that the administration of these 
prostaglandins brought about a sharp reduction in 
arterial blood pressures, is' 19 Thus it can be postu- 
lated that the ffect of furosemide on coronary flow 
is caused by an increase in the synthesis and release 
of prostaglandins from the coronary endothelial 
cells, which in turn vasodilate the coronary blood 
vessels. 
Furosemide is a loop diuretic agent commonly 
used in the treatment of patients with hypertension. 
In the present work, we have demonstrated its 
beneficial effect on the recovery of rat hearts pre- 
served in ST cardioplegic solution under hypother- 
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mic conditions. Although it has been reported that 
University of Wisconsin solution gives improved 
preservation results when compared with ST solu- 
tion, 2° we used the ST solution because of its wide 
use in clinical settings and because it is relatively 
simple to prepare. We believe that furosemide 
protects the myocardial tissue during hypothermic 
ischemic preservation by reducing the intracellular 
Na-- accumulation, which in turn suppresses the 
elevation of the intracellular free calcium via the 
Ca2+/Na + exchanger and reduces intracellular wa- 
ter accumulation as reflected by the reduction in 
mitochondrial swelling and damage, improved me- 
chanical recovery, and increased coronary flow. If 
furosemide is found to be effective in human hearts 
as well, it would be easy to introduce this agent to 
clinical use in heart preservation programs. 
We would like to thank Professor Yoram Lass for a 
helpful discussion, Dr. Ilana Gelerntner for the help in the 
statistical analysis, and Mrs. Ruth Panigel for her techni- 
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